Peng, Jenny
Sridhar, Srikala
Siefker-Radtke, Arlene Odelia
Selvarajah, Shamini
Jiang, Di Maria
Article History
Accepted: 1 August 2022
First Online: 13 August 2022
Compliance with Ethical Standards
:
: Jenny Peng declares that she has no conflict of interest. Srikala Sridhar has received grants from Bayer, Janssen, and Pfizer and has served as a consultant for Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Immunomedics, Janssen, Merck, Pfizer, Roche/Genentech, Sanofi, and Seattle Genetics. Arlene Odelia Siefker-Radtke has received grants from Basilea, BioClin Therapeutics, Bristol-Myers Squibb, Janssen, Merck Sharp & Dohme, and Michael and Sherry Sutton Fund for Urothelial Cancer, Nektar, NIH, Takeda, has royalties and patents for methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer, and has served as a consultant for AstraZeneca, Bavarian Nordic, Bristol-Myers Squibb, EMD Serono, Genentech, Janssen, Merck, Mirati Therapeutics, NCCN, Nektar, and Seattle Genetics. Shamini Selvarajah declares that she has no conflict of interest. Di Maria Jiang has served as a consultant for Bayer and EMD Serono Canada, has received honoraria for lectures for Janssen, Ipsen, Bayer, Amgen, and EMD Serono Canada, and has received support for attending meetings for EMD Serono.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).